February 2026
1. REINERT MS, Ryde HV, Sorensen LM, Johansen SE, et al
   Polycystic Ovarian Syndrome and the Long-Term Risk of Arrhythmias.
   Circulation. 2026;153:493-503.
   

   >> Share

   
   
2. HAIMOVICH JS, Kany S, Chang Y, Borowsky LH, et al
   Incidence, Risk Factors, and Outcomes in Stressor-Associated Atrial Fibrillation: Insights From the VITAL-AF Trial.
   Circulation. 2026;153:367-378.
   

   >> Share

   
   
3. VIRK SA, Kalman JM
   Stressor-Associated Atrial Fibrillation: Triggering the Arrhythmia or Unmasking the Substrate?
   Circulation. 2026;153:379-381.
   

   >> Share

   
   
4. CHEN Y, Pokorney SD, Lip GYH
   Off-Label Dapagliflozin After Atrial Fibrillation Ablation: A Reasonable Intervention or Overstretching the Evidence?
   Circulation. 2026;153:307-309.
   

   >> Share

   
   January 2026
5. AL SAID S, Braunwald E, Palazzolo MG, Melloni GEM, et al
   Systemic Embolic Events in Atrial Fibrillation: An Individual Patient Data Meta-analysis of 71 683 Participants Randomized to NOAC Versus Warfarin.
   Circulation. 2026 Jan 30. doi: 10.1161/CIRCULATIONAHA.125.075275.
   

   >> Share

   
   
6. MOORE BM, Chan D, Davies B, Laksman ZWM, et al
   Safety, Utility, and Outcomes of Procainamide Challenge for the Diagnosis and Exclusion of Brugada Syndrome.
   Circulation. 2026;153:154-163.
   

   >> Share

   
   
7. ANSARI RA, Bandyopadhyay S, Trivedi RK, Brennan KA, et al
   Deep Learning-Based Continuous QT Monitoring to Identify High-Risk Prolongation Events After Class III Antiarrhythmic Initiation.
   Circulation. 2026;153:35-46.
   

   >> Share

   
   December 2025
8. GUNAWARDENE MA, Schmidt B, Peichl P, Nair D, et al
   Life-Threatening Delayed Myocardial Ischemia and Malignant Arrhythmias Occurring After Pulsed Field Ablation of Atrial Fibrillation.
   Circulation. 2025 Dec 25. doi: 10.1161/CIRCULATIONAHA.125.077983.
   

   >> Share

   
   
9. D'AMBROSIO P, De Paepe J, Spencer LW, Ohanian M, et al
   Bradycardia in Athletes: Prevalence, Mechanisms, and Risks.
   Circulation. 2025 Dec 18. doi: 10.1161/CIRCULATIONAHA.125.076170.
   

   >> Share

   
   
10. WANNER JS, Krafft M, Niiranen T, Zimmerman DS, et al
    Leveraging a Genetic Proxy to Investigate the Effects of Lifelong Cardiac Sodium Channel Blockade.
    Circulation. 2025;152:1679-1690.
    

    >> Share

    
    
11. REDDY VY, Koruth JS, Peichl P, Petru J, et al
    High-Voltage Focal Pulsed Field Ablation to Treat Scar-Related Ventricular Tachycardia: The First-in-Human VCAS Trial.
    Circulation. 2025;152:1691-1704.
    

    >> Share

    
    
12. XU L, Hrybouski S, Liao TE, Dong JN, et al
    Geometric Features of Ventricular Tachycardia Corridors in Patients With Ischemic Cardiomyopathy.
    Circulation. 2025;152:1608-1620.
    

    >> Share

    
    
13. ZHANG Y, Zhao J, Wang X, Fan H, et al
    Modeling Long-QT Syndrome Using Gene-Edited Miniature Pigs.
    Circulation. 2025;152:1659-1662.
    

    >> Share

    
    
14. WU Y, Wang Z, Zuo Z
    Letter by Wu et al Regarding Article, "Bleeding and New Malignancy Diagnoses After Anticoagulation for Atrial Fibrillation: A Population-Based Cohort Study".
    Circulation. 2025;152:e420.
    

    >> Share

    
    
15. HU X, Arthur Vithran DT, Li H
    Letter by Hu et al Regarding Article, "Efficacy and Safety of Non-Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of 4 Randomized Clinical Trials
    Circulation. 2025;152:e423-e424.
    

    >> Share

    
    
16. PATEL SM, Giugliano RP
    Response by Patel and Giugliano to Letter Regarding Article, "Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of 4 Ran
    Circulation. 2025;152:e425-e426.
    

    >> Share

    
    
17. ABDEL-QADIR H, Grewal K, Wang X, Austin PC, et al
    Response by Abdel-Qadir et al to Letter Regarding Article, "Bleeding and New Malignancy Diagnoses After Anticoagulation for Atrial Fibrillation: A Population-Based Cohort Study".
    Circulation. 2025;152:e421-e422.
    

    >> Share

    
    November 2025
18. BERG DD
    Time for Precision Medicine in Atrial Fibrillation Management? Not So Fast.
    Circulation. 2025;152:1470-1472.
    

    >> Share

    
    
19. JIANG C, Zhao Z, Yang Z, Wang Y, et al
    Dapagliflozin to Reduce Early Recurrence After Catheter Ablation for Atrial Fibrillation: The DARE-AF Randomized Clinical Trial.
    Circulation. 2025 Nov 9. doi: 10.1161/CIRCULATIONAHA.125.077447.
    

    >> Share

    
    October 2025
20. RODES-CABAU J, Nombela-Franco L, Cruz-Gonzalez I, Hibbert B, et al
    Short-Term Anticoagulation versus Dual Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure: The ANDES Randomized Clinical Trial.
    Circulation. 2025 Oct 26. doi: 10.1161/CIRCULATIONAHA.125.077469.
    

    >> Share

    
    
21. LIU J, Zhang L, Chen Z
    Letter by Liu et al Regarding Article, "Risk of Incident Atrial Fibrillation in Women With a History of Hypertensive Disorders of Pregnancy: A Population-Based Retrospective Cohort Study".
    Circulation. 2025;152:e285-e286.
    

    >> Share

    
    
22. HUANG J
    Letter by Huang Regarding Article, "Risk of Incident Atrial Fibrillation in Women With a History of Hypertensive Disorders of Pregnancy: A Population-Based Retrospective Cohort Study".
    Circulation. 2025;152:e289-e290.
    

    >> Share

    
    
23. JOHNSTON A, Edwards JD, Coutinho T
    Response by Johnston et al to Letters Regarding Article, "Risk of Incident Atrial Fibrillation in Women With a History of Hypertensive Disorders of Pregnancy: A Population-Based Retrospective Cohort Study".
    Circulation. 2025;152:e291-e292.
    

    >> Share

    
    
24. FAUCHIER L, Lochon L, Lip GYH
    Letter by Fauchier et al Regarding Article, "Risk of Incident Atrial Fibrillation in Women With a History of Hypertensive Disorders of Pregnancy: A Population-Based Retrospective Cohort Study".
    Circulation. 2025;152:e287-e288.
    

    >> Share

    
    
25. KORNELIUS E
    Letter by Kornelius Regarding Article, "Risk of Incident Atrial Fibrillation in Women With a History of Hypertensive Disorders of Pregnancy: A Population-Based Retrospective Cohort Study".
    Circulation. 2025;152:e284.
    

    >> Share

    
    
26. LUO S, Xu Y, Zhang S, Rooney MR, et al
    Two-Week Atrial Fibrillation Burden and Incident Heart Failure Among Older Individuals in the ARIC Study.
    Circulation. 2025;152:1037-1039.
    

    >> Share

    
    September 2025
27. REDEL-TRAUB G, Marx SO, Marks AR
    Targeting Calcium Regulation for Heart Failure and Arrhythmia Therapeutics: A Critical Review.
    Circulation. 2025;152:957-970.
    

    >> Share

    
    
28. MORI Y, Sawano M, Kohsaka S, Tsugawa Y, et al
    Screening-Detected Atrial Fibrillation and Cardiovascular Outcomes in Working-Age Adults.
    Circulation. 2025 Sep 25. doi: 10.1161/CIRCULATIONAHA.125.074433.
    

    >> Share

    
    
29. SWEAT ME, Shi W, Sweat YY, Li J, et al
    TBX5 and CHD4 Coordinately Activate Atrial Cardiomyocyte Genes to Maintain Cardiac Rhythm Homeostasis.
    Circulation. 2025;152:784-801.
    

    >> Share

    
    August 2025
30. SOHNS C, Moersdorf M, Marrouche NF, Costard-Jaeckle A, et al
    3-Year Outcomes of Catheter Ablation in Patients with End-Stage Heart Failure and Atrial Fibrillation.
    Circulation. 2025 Aug 31. doi: 10.1161/CIRCULATIONAHA.125.075787.
    

    >> Share

    
    
31. OLDGREN J, Hijazi Z, Arheden H, Bjorkenheim A, et al
    Biomarker-based ABC-AF Risk Scores for Personalized Treatment to Reduce Stroke or Death in Atrial Fibrillation - a Registry-based Multicenter Randomized Controlled Study.
    Circulation. 2025 Aug 30. doi: 10.1161/CIRCULATIONAHA.125.076725.
    

    >> Share

    
    
32. STEG PG, Mesnier J
    Abelacimab Versus Rivaroxaban in Patients With Atrial Fibrillation Receiving Oral Antiplatelet Therapy: Definitely Safe, but How Effective?
    Circulation. 2025;152:297-299.
    

    >> Share

    
    July 2025
33. PERGOLA V, Trancuccio A, Kukavica D, Mazzanti A, et al
    Genotype-Specific Outcomes of Desmosomal Cardiomyopathies.
    Circulation. 2025;152:233-245.
    

    >> Share

    
    
34. PATEL SM, Ruff CT
    Probing the Proteome for Atrial Fibrillation.
    Circulation. 2025;152:230-232.
    

    >> Share

    
    
35. REN H, Qin Q, Dong Q, Ainiwaer A, et al
    Smartphone-Measured Heart Sounds for Atrial Fibrillation Screening in Community Populations.
    Circulation. 2025;152:283-285.
    

    >> Share

    
    
36. SOCHOROVA V, Kunstatova V, Osmancik P, Duska F, et al
    COOPERATIVE-PFA: A Three-Arm Randomized Controlled Trial.
    Circulation. 2025;152:150-159.
    

    >> Share

    
    
37. TIAHNYBIK J, Siebert M, Kamimura D, Yimer W, et al
    Physical Activity and Incident Atrial Fibrillation in African Americans: The Jackson Heart Study.
    Circulation. 2025;152:126-128.
    

    >> Share

    
    June 2025
38. AL SAID S, Patel SM, Giugliano RP, Morrow DA, et al
    Abelacimab Versus Rivaroxaban in Patients With Atrial Fibrillation on Antiplatelet Therapy: A Prespecified Analysis of the AZALEA-TIMI 71 Trial.
    Circulation. 2025 Jun 23. doi: 10.1161/CIRCULATIONAHA.125.074037.
    

    >> Share

    
    
39. MULLER SA, Asatryan B, Gasperetti A, Cramer MJ, et al
    Family Screening in Relatives at Risk for Plakophilin-2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy.
    Circulation. 2025 Jun 17. doi: 10.1161/CIRCULATIONAHA.125.074058.
    

    >> Share

    
    May 2025
40. PARK H, Norby FL, Kim D, Jang E, et al
    Proteomic Signatures for Risk Prediction of Atrial Fibrillation.
    Circulation. 2025 May 22. doi: 10.1161/CIRCULATIONAHA.124.073457.
    

    >> Share

    
    
41. PATEL SM, Giugliano RP, Ruff CT
    Factor XI Inhibition for Atrial Fibrillation: Where Do We Stand?
    Circulation. 2025;151:1433-1435.
    

    >> Share

    
    April 2025
42. ENRIQUEZ A, Yogasundaram H, Neira V, Guandalini G, et al
    Stepwise Anatomical Approach to Ablation of Intramural Outflow Tract Ventricular Arrhythmias Guided by Septal Coronary Venous Mapping.
    Circulation. 2025 Apr 26. doi: 10.1161/CIRCULATIONAHA.125.074175.
    

    >> Share

    
    
43. REDDY VY, Gerstenfeld EP, Schmidt B, Andrade JG, et al
    Pulsed Field Ablation of Persistent Atrial Fibrillation With Continuous ECG Monitoring Follow-Up: ADVANTAGE AF-Phase 2.
    Circulation. 2025 Apr 24. doi: 10.1161/CIRCULATIONAHA.125.074485.
    

    >> Share

    
    
44. NOZICA N, Tedrow U
    Assessing the Consequences of Retrograde and Transseptal Approaches to Ventricular Arrhythmia Ablation.
    Circulation. 2025;151:1060-1062.
    

    >> Share

    
    
45. PEIGH G, Rosemas SC, Roberts AI, Longacre C, et al
    Response by Peigh et al to Letter Regarding Article, "Association of Atrial Fibrillation Burden and Mortality Among Patients With Cardiac Implantable Electronic Devices".
    Circulation. 2025;151:e925.
    

    >> Share

    
    
46. LU X, Liu S, Chen S
    Letter by Lu et al Regarding Article, "Association of Atrial Fibrillation Burden and Mortality Among Patients With Cardiac Implantable Electronic Devices".
    Circulation. 2025;151:e923-e924.
    

    >> Share

    
    
47. ZOU Y, Lu J, Lian Z, Jia J, et al
    Modified mRNA Treatment Restores Cardiac Function in Desmocollin-2-Deficient Mouse Models of Arrhythmogenic Right Ventricular Cardiomyopathy.
    Circulation. 2025 Apr 11. doi: 10.1161/CIRCULATIONAHA.124.072340.
    

    >> Share

    
    March 2025
48. NIIRANEN TJ, Schnabel RB, Schutte AE, Biton Y, et al
    Hypertension and Atrial Fibrillation: A Frontier Review From the AF-SCREEN International Collaboration.
    Circulation. 2025;151:863-877.
    

    >> Share

    
    
49. SUN B, Ni M, Li Y, Song Z, et al
    Inositol 1,4,5-Trisphosphate Receptor 1 Gain-of-Function Increases the Risk for Cardiac Arrhythmias in Mice and Humans.
    Circulation. 2025;151:847-862.
    

    >> Share

    
    
50. CHEN L, Hu Y, Saguner AM, Bauce B, et al
    Natural History and Clinical Outcomes of Patients With DSG2/DSC2 Variant-Related Arrhythmogenic Right Ventricular Cardiomyopathy.
    Circulation. 2025 Mar 24. doi: 10.1161/CIRCULATIONAHA.124.072226.
    

    >> Share

    
    
51. MIYAUCHI S, Kawada-Matsuo M, Furusho H, Nishi H, et al
    Atrial Translocation of Porphyromonas gingivalis Exacerbates Atrial Fibrosis and Atrial Fibrillation.
    Circulation. 2025 Mar 18. doi: 10.1161/CIRCULATIONAHA.124.071310.
    

    >> Share

    
    February 2025
52. WAIGHT MC, Prakosa A, Li AC, Bunce N, et al
    Personalized Heart Digital Twins Detect Substrate Abnormalities in Scar-Dependent Ventricular Tachycardia.
    Circulation. 2025;151:521-533.
    

    >> Share

    
    
53. GREWAL K, Wang X, Austin PC, Jackevicius CA, et al
    Bleeding and New Malignancy Diagnoses After Anticoagulation for Atrial Fibrillation: A Population-Based Cohort Study.
    Circulation. 2025 Feb 20. doi: 10.1161/CIRCULATIONAHA.124.070865.
    

    >> Share

    
    
54. JOHNSTON A, Petrcich W, Smith GN, Fell DB, et al
    Risk of Incident Atrial Fibrillation in Women With a History of Hypertensive Disorders of Pregnancy: A Population-Based Retrospective Cohort Study.
    Circulation. 2025 Feb 11. doi: 10.1161/CIRCULATIONAHA.124.072418.
    

    >> Share

    
    
55. KANG J, Yoo JE, Jeon BJ, Im SI, et al
    Risk of Atrial Fibrillation After Hemorrhagic Stroke: A Nationwide Cohort Study With Propensity Score Matching.
    Circulation. 2025;151:331-333.
    

    >> Share

    
    January 2025
56. 
    Correction to: Risk of Stroke or Systemic Embolism According to Baseline Frequency and Duration of Subclinical Atrial Fibrillation: Insights From the ARTESiA Trial.
    Circulation. 2025;151:e29.
    

    >> Share

    
    
57. WALSH R, Mauleekoonphairoj J, Mengarelli I, Bosada FM, et al
    A Rare Noncoding Enhancer Variant in SCN5A Contributes to the High Prevalence of Brugada Syndrome in Thailand.
    Circulation. 2025;151:31-44.
    

    >> Share

    
    
58. KOWLGI GN, Asirvatham SJ, Siontis KC
    What Is the Mechanism of Atrial Fibrillation Initiation?
    Circulation. 2025;151:120-122.
    

    >> Share

    
    December 2024
59. SHI Q, Wang J, Malik H, Li X, et al
    IRS2 Signaling Protects Against Stress-Induced Arrhythmia by Maintaining Ca(2+) Homeostasis.
    Circulation. 2024;150:1966-1983.
    

    >> Share

    
    
60. DOI SN, Butt JH, Thune JJ, Nielsen JC, et al
    Left Ventricular Ejection Fraction and Implantable Cardioverter-Defibrillator in Non-ischemic Heart Failure with Reduced Ejection Fraction: Insights from DANISH.
    Circulation. 2024 Dec 10. doi: 10.1161/CIRCULATIONAHA.124.071777.
    

    >> Share

    
    
61. O'NEILL MJ, Ng CA, Aizawa T, Sala L, et al
    Multiplexed Assays of Variant Effect and Automated Patch Clamping Improve KCNH2-LQTS Variant Classification and Cardiac Event Risk Stratification.
    Circulation. 2024;150:1869-1881.
    

    >> Share

    
    November 2024
62. JI Y, Zhang MJ, Wang W, Norby FL, et al
    Association of Coagulation Factor XI Level With Cardiovascular Events and Cardiac Function in Community-Dwelling Adults: From ARIC and CHS.
    Circulation. 2024 Nov 21. doi: 10.1161/CIRCULATIONAHA.124.070278.
    

    >> Share

    
    
63. HAUGUEL-MOREAU M, Guedeney P, Dauphin C, Auffret V, et al
    Flecainide to Prevent Atrial Arrhythmia After Patent Foramen Ovale Closure: AFLOAT Study, A Randomized Clinical Trial.
    Circulation. 2024;150:1659-1668.
    

    >> Share

    
    
64. LUCIJANIC M, Krecak I
    Letter by Lucijanic and Krecak Regarding Article, "Clonal Hematopoiesis of Indeterminate Potential With Loss of Tet2 Enhances Risk for Atrial Fibrillation Through Nlrp3 Inflammasome Activation".
    Circulation. 2024;150:e447-e448.
    

    >> Share

    
    October 2024
65. STIEGLIS R, Verkaik BJ, Tan HL, Koster RW, et al
    Association Between Delay to First Shock and Successful First-Shock Ventricular Fibrillation Termination in Patients With Witnessed Out-of-Hospital Cardiac Arrest.
    Circulation. 2024 Oct 27. doi: 10.1161/CIRCULATIONAHA.124.069834.
    

    >> Share

    
    
66. WEDIN JO, Naslund V, Rodin S, Simonson OE, et al
    Conduction Disturbances and Outcome After Surgical Aortic Valve Replacement in Patients With Bicuspid and Tricuspid Aortic Stenosis.
    Circulation. 2024 Oct 23. doi: 10.1161/CIRCULATIONAHA.124.070753.
    

    >> Share

    
    
67. SOHNS C, Sommer P
    Patients With Advanced Heart Failure and Atrial Fibrillation Deserve an Attempt at Catheter Ablation as First-Line Therapy.
    Circulation. 2024;150:1220-1222.
    

    >> Share

    
    
68. GOPINATHANNAIR R, Olshansky B, Chung MK, Gordon S, et al
    Cardiac Arrhythmias and Autonomic Dysfunction Associated With COVID-19: A Scientific Statement From the American Heart Association.
    Circulation. 2024 Oct 14. doi: 10.1161/CIR.0000000000001290.
    

    >> Share

    
    
69. ALDAAS OM, Aldaas AM, Hsu JC
    Letter by Aldaas et al Regarding Article, "Direct Oral Anticoagulants for Stroke Prevention in Patients With Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials".
    Circulation. 2024;150:e273.
    

    >> Share

    
    
70. MCINTYRE WF, Benz AP, Healey JS, Lopes R, et al
    Response by McIntyre et al to Letter Regarding Article, "Direct Oral Anticoagulants for Stroke Prevention in Patients With Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials".
    Circulation. 2024;150:e274-e275.
    

    >> Share

    
    
71. BORTOLIN RH, Nawar F, Park C, Trembley MA, et al
    Antisense Oligonucleotide Therapy for Calmodulinopathy.
    Circulation. 2024;150:1199-1210.
    

    >> Share

    
    
72. SCHMIDT B, Bordignon S, Metzner A, Sommer P, et al
    Ablation Strategies for Repeat Procedures in Atrial Fibrillation Recurrences Despite Durable Pulmonary Vein Isolation: The Prospective Randomized ASTRO AF Multicenter Trial.
    Circulation. 2024 Oct 7. doi: 10.1161/CIRCULATIONAHA.124.069993.
    

    >> Share

    
    September 2024
73. FRIEDMAN P, Murgatroyd F, Boersma LVA, Manlucu J, et al
    Performance and Safety of the Extravascular Implantable Cardioverter-Defibrillator Through Long-Term Follow-Up: Final Results From the Pivotal Study.
    Circulation. 2024 Sep 26. doi: 10.1161/CIRCULATIONAHA.124.071795.
    

    >> Share

    
    
74. RAJENDRAN K, Alphonse AJ, Desabandhu V
    ECG Changes in a Patient With Recurrent Palpitations.
    Circulation. 2024;150:1061-1063.
    

    >> Share

    
    
75. LI J, Janin A, Patoughi M, Gaudreault N, et al
    Circulating Autoantibodies Targeting TREK-1 in Patients With Short-Coupled Ventricular Fibrillation.
    Circulation. 2024 Sep 24. doi: 10.1161/CIRCULATIONAHA.124.070284.
    

    >> Share

    
    
76. REDDY VY, Calkins H, Mansour M, Wazni O, et al
    Pulsed Field Ablation to Treat Paroxysmal Atrial Fibrillation: Safety and Effectiveness in the ADMIRE Pivotal Trial.
    Circulation. 2024 Sep 11. doi: 10.1161/CIRCULATIONAHA.124.070333.
    

    >> Share

    
    
77. MCINTYRE WF, Benz AP, Healey JS, Connolly SJ, et al
    Risk of Stroke or Systemic Embolism According to Baseline Frequency and Duration of Subclinical Atrial Fibrillation: Insights From the ARTESiA Trial.
    Circulation. 2024 Sep 4. doi: 10.1161/CIRCULATIONAHA.124.069903.
    

    >> Share

    
    
78. KEMP GUDMUNDSDOTTIR K, Svennberg E, Friberg L, Hygrell T, et al
    Randomized Invitation to Systematic NT-proBNP and ECG Screening in 75-Year Olds to Detect Atrial Fibrillation -STROKESTOP II.
    Circulation. 2024 Sep 1. doi: 10.1161/CIRCULATIONAHA.124.071176.
    

    >> Share

    
    August 2024
79. SOHNS C, Moersdorf M, Marrouche NF, Bergau L, et al
    Catheter Ablation in Patients with End-Stage Heart Failure and Atrial Fibrillation: Two-year Follow-up of the CASTLE-HTx Trial.
    Circulation. 2024 Aug 30. doi: 10.1161/CIRCULATIONAHA.124.071517.
    

    >> Share

    
    
80. VISKIN S, Chorin E, Rosso R, Amin AS, et al
    Diagnosis of Brugada Syndrome With a Sodium-Channel-Blocker Test: Who Should Be Tested? Who Should Not?
    Circulation. 2024;150:642-650.
    

    >> Share

    
    
81. KOBAYASHI H, Tohyama S, Ichimura H, Ohashi N, et al
    Regeneration of Nonhuman Primate Hearts With Human Induced Pluripotent Stem Cell-Derived Cardiac Spheroids.
    Circulation. 2024;150:611-621.
    

    >> Share

    
    
82. AL SAYED ZR, Pereira C, Le Borgne R, Viaris de Lesegno C, et al
    CAVIN1-Mediated hERG Dynamics: A Novel Mechanism Underlying the Interindividual Variability in Drug-Induced Long QT.
    Circulation. 2024;150:563-576.
    

    >> Share

    
    
83. MARCUS MD, Link MS
    Omega-3 Fatty Acids and Arrhythmias.
    Circulation. 2024;150:488-503.
    

    >> Share

    
    
84. MONDAL S, Abhilash SP, Namboodiri N
    Recognition of an Unusual Pattern in a Case of Narrow Complex Tachycardia.
    Circulation. 2024;150:506-508.
    

    >> Share

    
    
85. SVEDBERG N, Sundstrom J, James S, Hallmarker U, et al
    Long-Term Incidence of Bradycardia and Pacemaker Implantations Among Cross-Country Skiers: A Cohort Study.
    Circulation. 2024 Aug 5. doi: 10.1161/CIRCULATIONAHA.123.068280.
    

    >> Share

    
    July 2024
86. LAMBIASE PD, van Duijvenboden S
    Response by Lambiase and van Duijvenboden to Letter Regarding Article, "Prognostic Significance of Different Ventricular Ectopic Burdens During Submaximal Exercise in Asymptomatic UK Biobank Subjects".
    Circulation. 2024;150:e104.
    

    >> Share

    
    
87. KATSOURAS CS
    Letter by Katsouras Regarding Article, "Prognostic Significance of Different Ventricular Ectopic Burdens During Submaximal Exercise in Asymptomatic UK Biobank Subjects".
    Circulation. 2024;150:e102-e103.
    

    >> Share

    
    
88. LAMPERT R, Day S, Ainsworth B, Burg M, et al
    Vigorous Exercise in Patients With Congenital Long-QT Syndrome: Results of the Prospective, Observational, Multinational LIVE-LQTS Study.
    Circulation. 2024 Jul 25. doi: 10.1161/CIRCULATIONAHA.123.067590.
    

    >> Share

    
    
89. AULIN J, Sjolin K, Lindback J, Benz AP, et al
    Neurofilament Light Chain and Risk of Stroke in Patients With Atrial Fibrillation.
    Circulation. 2024 Jul 24. doi: 10.1161/CIRCULATIONAHA.124.069440.
    

    >> Share

    
    
90. WAN EY, Rogers AJ, Lavelle M, Marcus M, et al
    Periprocedural Management and Multidisciplinary Care Pathways for Patients With Cardiac Implantable Electronic Devices: A Scientific Statement From the American Heart Association.
    Circulation. 2024 Jul 10. doi: 10.1161/CIR.0000000000001264.
    

    >> Share

    
    
91. HEIJMAN J, Dobrev D
    Spexin Hormone Signaling and Atrial Fibrillation: The Knowns and Unknowns.
    Circulation. 2024;150:128-131.
    

    >> Share

    
    
92. VAN DOORN S, Rutten FH, Geersing GJ
    Response by van Doorn et al to Letters Regarding Article, "Safety of Switching From a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled
    Circulation. 2024;150:e30-e32.
    

    >> Share

    
    
93. KO D, Kim DH, Singer DE
    Letter by Ko et al Regarding Article, "Safety of Switching From a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial".
    Circulation. 2024;150:e25-e26.
    

    >> Share

    
    
94. SUWA M, Morii I, Kino M
    Letter by Suwa et al Regarding Article, "Safety of Switching From a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial".
    Circulation. 2024;150:e27.
    

    >> Share

    
    
95. MILLIS CE, Feradov DF, Prida XE
    Letter by Millis et al Regarding Article, "Safety of Switching From a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial".
    Circulation. 2024;150:e23-e24.
    

    >> Share

    
    
96. LIN Y
    Letter by Lin Regarding Article, "Safety of Switching from a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients with Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial".
    Circulation. 2024;150:e21-e22.
    

    >> Share

    
    
97. KOHSAKA S, Nishimura S, Kumamaru H
    Letter by Kohsaka et al Regarding Article, "Safety of Switching From a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial".
    Circulation. 2024;150:e28-e29.
    

    >> Share

    
    
98. ORAL H, Morady F
    Ablation of Cardiac Arrhythmias: Past, Present, and Future.
    Circulation. 2024;150:4-6.
    

    >> Share

    
    
99. 
    Correction to: Early Versus Late Initiation of Direct Oral Anticoagulants After Ischemic Stroke in People With Atrial Fibrillation and Hemorrhagic Transformation: Prespecified Subanalysis of the Randomized Controlled ELAN Trial.
    Circulation. 2024;150:e20.
    

    >> Share

    
    June 2024
100. PEIGH G, Zhou J, Rosemas SC, Roberts AI, et al
     Association of Atrial Fibrillation Burden and Mortality Among Patients With Cardiac Implantable Electronic Devices.
     Circulation. 2024 Jun 28. doi: 10.1161/CIRCULATIONAHA.124.069757.
     

     >> Share

     
     
101. CROTTI L, Neves R, Dagradi F, Musu G, et al
     Therapeutic Efficacy of Mexiletine for Long QT Syndrome Type 2: Evidence From Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes, Transgenic Rabbits, and Patients.
     Circulation. 2024 Jun 28. doi: 10.1161/CIRCULATIONAHA.124.068959.
     

     >> Share

     
     
102. FAKUADE FE, Hubricht D, Moller V, Sobitov I, et al
     Impaired Intracellular Calcium Buffering Contributes to the Arrhythmogenic Substrate in Atrial Myocytes From Patients With Atrial Fibrillation.
     Circulation. 2024 Jun 24. doi: 10.1161/CIRCULATIONAHA.123.066577.
     

     >> Share

     
     
103. GROUSSIN P, Melot A, Martins RP
     PVC or Not PVC? That Is the Question.
     Circulation. 2024;149:1927-1930.
     

     >> Share

     
     
104. 
     Correction to: 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
     Circulation. 2024;149:e1413.
     

     >> Share

     
     
105. LEE CH, Higgs E, Scheinman MM
     A Wide Complex Tachycardia.
     Circulation. 2024;149:1852-1854.
     

     >> Share

     
     May 2024
106. ENSAM B, Scrocco C, Johnson D, Wijeyeratne YD, et al
     Type 1 Brugada Pattern May Be Provoked by Ajmaline in Some Healthy Subjects: Results From a Clinical Trial.
     Circulation. 2024;149:1693-1695.
     

     >> Share

     
     
107. ROHNER R, Kneihsl M, Goeldlin MB, Hakim A, et al
     Early Versus Late Initiation of Direct Oral Anticoagulants After Ischemic Stroke in People With Atrial Fibrillation and Hemorrhagic Transformation: Prespecified Subanalysis of the Randomized-controlled ELAN Trial.
     Circulation. 2024 May 16. doi: 10.1161/CIRCULATIONAHA.124.069324.
     

     >> Share

     
     
108. MAHESH M, Mantoo MR, Makkar N
     Left Ventricular Hypertrophy With Preexcitation.
     Circulation. 2024;149:1614-1616.
     

     >> Share

     
     
109. LI D, Liu Y, Li C, Zhou Z, et al
     Spexin Diminishes Atrial Fibrillation Vulnerability by Acting on Galanin Receptor 2.
     Circulation. 2024 May 10. doi: 10.1161/CIRCULATIONAHA.123.067517.
     

     >> Share

     
     April 2024
110. MAYER M
     Letter by Mayer Regarding Article, "Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants".
     Circulation. 2024;149:e1109-e1110.
     

     >> Share

     
     
111. AGGARWAL R, Ruff CT, Virdone S, Perreault S, et al
     Response by Aggarwal et al to Letter Regarding Article, "Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants".
     Circulation. 2024;149:e1111-e1112.
     

     >> Share

     
     
112. CHUGH SS
     Prevention of Sudden Cardiac Death: Beyond Automated External Defibrillators and Implantable Cardioverter Defibrillators.
     Circulation. 2024;149:1059-1061.
     

     >> Share

     
     March 2024
113. PATEL SM, Ruff CT
     Subclinical Atrial Fibrillation and Anticoagulation: Weighing the Absolute Risks and Benefits.
     Circulation. 2024;149:989-992.
     

     >> Share

     
     
114. REIFFEL JA
     Atrial Fibrillation: Why Are We Hiding Reality?
     Circulation. 2024;149:979-980.
     

     >> Share

     
     
115. LEE CH, Scheinman MM
     Wide Complex Tachycardia: Mind Your Medicine!
     Circulation. 2024;149:963-966.
     

     >> Share

     
     
116. KOWEY PR, Naccarelli GV
     Antiarrhythmic Drug Therapy: Where Do We Go From Here?
     Circulation. 2024;149:801-803.
     

     >> Share

     
     
117. KLEIMAN NS, Goel SS
     The Shape of Things to Come? Is a Trial of Combined Interventional Procedures Necessary in Today's World?
     Circulation. 2024;149:744-746.
     

     >> Share

     
     
118. BATRA AS, Silka MJ, Borquez A, Cuneo B, et al
     Pharmacological Management of Cardiac Arrhythmias in the Fetal and Neonatal Periods: A Scientific Statement From the American Heart Association: Endorsed by the Pediatric & Congenital Electrophysiology Society (PACES).
     Circulation. 2024;149:e937-e952.
     

     >> Share

     
     February 2024
119. 
     Correction to: 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
     Circulation. 2024;149:e936.
     

     >> Share

     
     
120. HOEDEMAKERS S, Pugliese NR, Stassen J, Vanoppen A, et al
     mPAP/CO Slope and Oxygen Uptake Add Prognostic Value in Aortic Stenosis.
     Circulation. 2024 Feb 27. doi: 10.1161/CIRCULATIONAHA.123.067130.
     

     >> Share

     
     
121. LIN AE, Bapat AC, Xiao L, Niroula A, et al
     Clonal Hematopoiesis of Indeterminate Potential With Loss of Tet2 Enhances Risk for Atrial Fibrillation Through Nlrp3 Inflammasome Activation.
     Circulation. 2024 Feb 15. doi: 10.1161/CIRCULATIONAHA.123.065597.
     

     >> Share

     
     
122. SANCHEZ RH, Hamdan H, Torrealba J, Grodin JL, et al
     Giants Hiding in Small Places: A Case of New Onset Heart Failure, Atrioventricular Block, and Ventricular Arrhythmias.
     Circulation. 2024;149:475-480.
     

     >> Share

     
     
123. GALEA R, Meneveau N, De Marco F, Aminian A, et al
     One-Year Outcomes After Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: A Prespecified Analysis of the SWISS-APERO Randomized Clinical Trial.
     Circulation. 2024;149:484-486.
     

     >> Share

     
     January 2024
124. LEE SY, Lee BK
     Palpitations and Recurrent Syncope in a Young Woman.
     Circulation. 2024;149:402-405.
     

     >> Share

     
     
125. HERWEG B, Sharma PS, Cano O, Ponnusamy SS, et al
     Arrhythmic Risk in Biventricular Pacing Compared With Left Bundle Branch Area Pacing: Results From the I-CLAS Study.
     Circulation. 2024;149:379-390.
     

     >> Share

     
     
126. PATEL SM, Braunwald E, Steffel J, Boriani G, et al
     Efficacy and Safety of Non-Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of Four Randomized Clinical Trials of 58 464 Patients With Atrial Fibr
     Circulation. 2024 Jan 24. doi: 10.1161/CIRCULATIONAHA.123.066279.
     

     >> Share

     
     
127. WALLENTIN L, Giugliano RP
     Switching to Direct Anticoagulation or Continued Vitamin-K Antagonists in Frail Patients With Atrial Fibrillation in Whom Vitamin-K Antagonists Are Tolerated?
     Circulation. 2024;149:290-292.
     

     >> Share

     
     
128. BROMAN MT, Nadadur RD, Perez-Cervantes C, Burnicka-Turek O, et al
     A Genomic Link From Heart Failure to Atrial Fibrillation Risk: FOG2 Modulates a TBX5/GATA4-Dependent Atrial Gene Regulatory Network.
     Circulation. 2024 Jan 8. doi: 10.1161/CIRCULATIONAHA.123.066804.
     

     >> Share

     
     
129. 
     Correction to: 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
     Circulation. 2024;149:e167.
     

     >> Share

     
     December 2023
130. OSTERGAARD L, Olesen JB, Petersen JK, Nielsen LS, et al
     Arterial Thromboembolism in Patients With Atrial Fibrillation and CHA(2)DS(2)-VASc 1: A Nationwide Study.
     Circulation. 2023 Dec 28. doi: 10.1161/CIRCULATIONAHA.123.066477.
     

     >> Share

     
     
131. BERGEMAN AT, Lieve KVV, Kallas D, Bos JM, et al
     Flecainide Is Associated With a Lower Incidence of Arrhythmic Events in a Large Cohort of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia.
     Circulation. 2023;148:2029-2037.
     

     >> Share

     
     
132. VAN DUIJVENBODEN S, Ramirez J, Orini M, Aung N, et al
     Prognostic Significance of Different Ventricular Ectopic Burdens During Submaximal Exercise in Asymptomatic UK Biobank Subjects.
     Circulation. 2023;148:1932-1944.
     

     >> Share

     
     
133. KATAOKA N, Imamura T, Kinugawa K
     Letter by Kataoka et al Regarding Article, "Long-Term Outcomes of Brugada Substrate Ablation: A Report From BRAVO (Brugada Ablation of VF Substrate Ongoing Multicenter Registry)".
     Circulation. 2023;148:1914.
     

     >> Share

     
     November 2023
134. JOGLAR JA, Chung MK, Armbruster AL, Benjamin EJ, et al
     2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
     Circulation. 2023 Nov 30. doi: 10.1161/CIR.0000000000001193.
     

     >> Share

     
     
135. KHIDHIR A, Curtis AB
     Perspective on ACC/AHA/ACCP/HRS Guidelines for the Management of Atrial Fibrillation.
     Circulation. 2023 Nov 30. doi: 10.1161/CIRCULATIONAHA.123.066919.
     

     >> Share

     
     
136. ROWIN EJ, Link MS, Maron MS, Maron BJ, et al
     Evolving Contemporary Management of Atrial Fibrillation in Hypertrophic Cardiomyopathy.
     Circulation. 2023;148:1797-1811.
     

     >> Share

     
     
137. HIGUCHI S, Voskoboinik A, Il Im S, Lee A, et al
     Frequent Premature Atrial Contractions Lead to Adverse Atrial Remodeling and Atrial Fibrillation in a Swine Model.
     Circulation. 2023 Nov 23. doi: 10.1161/CIRCULATIONAHA.123.065874.
     

     >> Share

     
     
138. GONZALEZ-TORRECILLA E, Luna Lopez R, Avila Alonso P
     Atrioventricular Block: Does This Patient Require a Pacemaker?
     Circulation. 2023;148:1725-1727.
     

     >> Share

     
     
139. SEO K, Yamamoto Y, Kirillova A, Kawana M, et al
     Improved Cardiac Performance and Decreased Arrhythmia in Hypertrophic Cardiomyopathy With Non-beta-Blocking R-Enantiomer Carvedilol.
     Circulation. 2023;148:1691-1704.
     

     >> Share

     
     
140. QI M, Ma S, Liu J, Liu X, et al
     In Vivo Base Editing of Scn5a Rescues Type 3 Long QT Syndrome in Mice.
     Circulation. 2023 Nov 15. doi: 10.1161/CIRCULATIONAHA.123.065624.
     

     >> Share

     
     
141. WILDE AAM, Saenen J
     Risk Stratification in Brugada Syndrome: How Low Can We Go?
     Circulation. 2023;148:1556-1558.
     

     >> Share

     
     
142. BELBACHIR N, Wu Y, Shen M, Zhang SL, et al
     Studying Long QT Syndrome Caused by NAA10 Genetic Variants Using Patient-Derived Induced Pluripotent Stem Cells.
     Circulation. 2023;148:1598-1601.
     

     >> Share

     
     
143. KIM MC, Lim Y, Lee SH, Shin Y, et al
     Early Left Ventricular Unloading or Conventional Approach After Venoarterial Extracorporeal Membrane Oxygenation: The EARLY-UNLOAD Randomized Clinical Trial.
     Circulation. 2023;148:1570-1581.
     

     >> Share

     
     
144. GAITA F, Cerrato N, Giustetto C, Martino A, et al
     Asymptomatic Patients With Brugada ECG Pattern: Long-Term Prognosis From a Large Prospective Study.
     Circulation. 2023;148:1543-1555.
     

     >> Share

     
     
145. HOSOKAWA K, Watanabe H, Taniguchi Y, Ikeda N, et al
     A Multicenter, Single-Blind, Randomized, Warfarin-Controlled Trial of Edoxaban in Patients With Chronic Thromboembolic Pulmonary Hypertension: KABUKI Trial.
     Circulation. 2023 Nov 13. doi: 10.1161/CIRCULATIONAHA.123.067528.
     

     >> Share

     
     
146. MCINTYRE WF, Benz AP, Becher N, Healey JS, et al
     Direct Oral Anticoagulants for Stroke Prevention in Patients with Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials.
     Circulation. 2023 Nov 12. doi: 10.1161/CIRCULATIONAHA.123.067512.
     

     >> Share

     
     
147. POKORNEY SD, Granger CB
     The Need for Randomized Trials to Define the Optimal Dose of Anticoagulants for Atrial Fibrillation in Chronic Kidney Disease.
     Circulation. 2023;148:1455-1458.
     

     >> Share

     
     October 2023
148. STEVENSON WG, Tandri H, Roden DM
     The Shape of Ventricular Tachycardia.
     Circulation. 2023;148:1368-1370.
     

     >> Share

     
     
149. NISHIMURA T, Shatz N, Weiss JP, Zawaneh M, et al
     Identification of Human Ventricular Tachycardia Demarcated by Fixed Lines of Conduction Block in a 3-Dimensional Hyperboloid Circuit.
     Circulation. 2023;148:1354-1367.
     

     >> Share

     
     
150. KAPADIA SR, Krishnaswamy A, Whisenant B, Potluri S, et al
     Concomitant Left Atrial Appendage Occlusion and Transcatheter Aortic Valve Replacement Among Patients with Atrial Fibrillation.
     Circulation. 2023 Oct 24. doi: 10.1161/CIRCULATIONAHA.123.067312.
     

     >> Share

     
     
151. O'HARA PE, Venkatesh V, Lehrenbaum H
     A Unique Case of Right Axis Deviation.
     Circulation. 2023;148:1261-1262.
     

     >> Share

     
     
152. KRISAI P, Kuhne M, Sticherling C
     Letter by Krisai et al Regarding Article, "Pulsed Field Ablation for the Treatment of Atrial Fibrillation: PULSED AF Pivotal Trial".
     Circulation. 2023;148:1182.
     

     >> Share

     
     
153. BUTT JH, Yafasova A, Doi SN, Nielsen JC, et al
     Implantable Cardioverter Defibrillator in Patients With Nonischemic Systolic Heart Failure With and Without Cardiac Resynchronization Therapy: Extended Follow-Up Study of the DANISH Trial.
     Circulation. 2023;148:1179-1181.
     

     >> Share

     
     September 2023
154. PARKASH R, O'Meara E, Tang ASL
     The Role of Ablation-Based Rhythm Control in the Tangled Web of Atrial Fibrillation and Heart Failure.
     Circulation. 2023;148:933-935.
     

     >> Share

     
     
155. EZEKOWITZ MD, Kamareddine M
     Filling an Important Knowledge Gap: The DOAC Score.
     Circulation. 2023;148:947-949.
     

     >> Share

     
     
156. PERERA D, Morgan HP, Ryan M, Dodd M, et al
     Arrhythmia and Death Following Percutaneous Revascularization in Ischemic Left Ventricular Dysfunction: Prespecified Analyses From the REVIVED-BCIS2 Trial.
     Circulation. 2023;148:862-871.
     

     >> Share

     
     
157. XU Y, Chang AR, Inker LA, McAdams-DeMarco M, et al
     Associations of Apixaban Dose With Safety and Effectiveness Outcomes in Patients With Atrial Fibrillation and Severe Chronic Kidney Disease.
     Circulation. 2023 Sep 8. doi: 10.1161/CIRCULATIONAHA.123.065614.
     

     >> Share

     
     
158. PUNDI K, Marcus GM, Turakhia M
     The Epidemic and Data-Free Zone of Nonsustained Ventricular Tachycardia: An Unintended Consequence of Digital Monitoring and a Path Forward.
     Circulation. 2023;148:805-807.
     

     >> Share

     
     
159. XIAO SY, Goldschlager N, Durstenfeld MS
     Chest Pain, Bundle Branch Block, and Wide Complex Tachycardia: Is Three a Company or Crowd?
     Circulation. 2023;148:845-847.
     

     >> Share

     
     

Free Medical Abstracts
Privacy Policy
Sponsors
Share